Development of a Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 63
- 试验地点
- 1
- 主要终点
- Antiretroviral Therapy (ART) Adherence Levels
研究概览
简要总结
Development of Real-Time Antiretroviral Therapy Adherence Intervention in Uganda (The Wisepill Study).
详细描述
In this study, the investigators propose to develop a real-time adherence intervention based on SMS (i.e., text messages), wireless adherence monitoring (with the Wisepill device), and engagement of social support that is tailored to rural sub-Saharan Africa. The investigators will build on research by others who have shown SMS reminders improve adherence and viral suppression in Kenya, albeit with relatively small effect sizes and suboptimal virologic failure rates even in the intervention arm. Moreover, little is known about which patients benefit from SMS, why they benefit, and what can be done to further improve adherence and treatment success rates. Understanding the mechanisms of effect will make it possible to design and test evidence-based interventions with the highest likelihood for efficacy.
In a cohort of HIV-infected individuals starting ART and being monitored with Wisepill, the investigators will test 1) daily SMS reminders, 2) weekly SMS reminders, 3) SMS reminders linked to real-time detection of missed doses, and 4) SMS reminders plus SMS notifications of 48+hour gaps in adherence to members of social support networks. The investigators will conduct qualitative interviews to learn the experiences of participants and members of their social support networks with the different types of SMS. This staged approach will allow us to fully understand and compare the additive effects and acceptability of SMS-based interventions. The investigators will also determine behavioral effect mechanisms, as well as compare the impact of each type of SMS with a control population receiving only Wisepill monitoring on adherence and HIV RNA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HIV-infected
- •Initiating ART within the next two weeks
- •Age 18 years and older
- •Owns a cell phone for personal use and has reliable cellular phone reception at home on a network supported by the technology used in this study
- •Lives in the Mbarara District (i.e, within 20 km of the ISS Clinic)
- •Has at least one person who could be named as a social supporter(see criteria below).
排除标准
- •Unable to use SMS
- •Unwilling to receive SMS reminders
- •Severe mental condition limiting the ability to provide consent
- •Cellular phone reception is not reliable
- •Social supporters (i.e., recipients of the SMS notifications for Wisepill participants in the intervention arms):
- •Inclusion criteria:
- •Knows Wisepill participant has HIV
- •Age 18 years or older
- •Reports having provided social support to the intervention participant at least once
- •Own a cell phone for personal use and have reliable cellular phone reception at home on a network supported by the technology used in this study
- •Lives in the Mbarara District
- •Exclusion criteria:
- •Unable to use SMS
- •Unwilling to receive SMS notifications regarding interruptions in the intervention participant's adherence
- •Severe mental condition limiting the ability to provide consent
结局指标
主要结局
Antiretroviral Therapy (ART) Adherence Levels
时间窗: real time (for 9 months)
ART adherence in each study arms. Adherence is measured by the Wisepill real-time adherence monitor and calculated as the number of monitor opening signals received divided by the number of monitor opening signals expected, capped at 100%.
次要结局
- HIV RNA Suppression(After month 9)
研究者
Jessica Haberer, MD
Assistant Professor of Medicine
Massachusetts General Hospital
